Literature DB >> 2112121

Shielding considerations for an operating room based intraoperative electron radiotherapy unit.

M D Mills1, P R Almond, A L Boyer, T G Ochran, W Madigan, T A Rich, E B Dally.   

Abstract

The leakage radiation characteristics of a dedicated intraoperative radiotherapy linear accelerator have been measured on a machine designed to minimize the shielding required to allow it to be placed in an operating room suite. The scattering foil design was optimized to produce a flat beam for the field sizes employed while generating minimal bremsstrahlung contamination over the available energy range. More lead shielding was used in the treatment head than is used in conventional accelerators. A small amount of borated polyethylene shielding was also employed since neutron production was present at measurable levels. The room shielding installed in the operating room was demonstrated to be adequate to treat at least 20 patients each month to an average dose of 20 Gy. The worst case exposure was found to be 73% maximum permissible exposure. Administrative control was required for adjoining areas when calibrations and maintenance were performed.

Entities:  

Mesh:

Year:  1990        PMID: 2112121     DOI: 10.1016/0360-3016(90)90460-2

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  4 in total

1.  Shielding assessment of a mobile electron accelerator for intraoperative radiotherapy.

Authors:  J L Daves; M D Mills
Journal:  J Appl Clin Med Phys       Date:  2001       Impact factor: 2.102

2.  Intraoperative radiation therapy following pancreaticoduodenectomy.

Authors:  D B Evans; P M Termuhlen; D R Byrd; F C Ames; T G Ochran; T A Rich
Journal:  Ann Surg       Date:  1993-07       Impact factor: 12.969

3.  Shielding assessment of a mobile electron accelerator for intra-operative radiotherapy.

Authors:  Alexandre S Krechetov; Donald Goer; Kate Dikeman; Jodi L Daves; Michael D Mills
Journal:  J Appl Clin Med Phys       Date:  2010-09-07       Impact factor: 2.102

4.  Dose consumption for quality assurance and maintenance at a dedicated IORT accelerator.

Authors:  Frank W Hensley
Journal:  J Appl Clin Med Phys       Date:  2009-10-27       Impact factor: 2.102

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.